Zahraa Mohammed Kadhim

Zahraa Mohammed Kadhim

Auto-generated profile, based on publicly available information

Zahraa Mohammed Kadhim


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2026 in Wiadomości Lekarskie
Verified
Journal Article
Closed access
PDF file
MAMaryam Alaayedi
Maryam Alaayedi
ZKZahraa Mohammed Kadhim
Zahraa Mohammed Kadhim
JAJamal Ali Ashoor
Jamal Ali Ashoor
ASAshti Mh Saeed
Ashti Mh Saeed
JAJinan M Al-Mousawy
Jinan M Al-Mousawy
MAMustafa H. Alhamadani
Mustafa H. Alhamadani
Aim: methotrexate was formulated as Ethosomal gel for enhancing the therapeutic performance and stability to treat cervical cancer via targeting the drug locally through cervical mucosa to avoid the systemic adverse effect of the chemotherapy. Materials and Methods: The formulations were produced using phospholipid and cholesterol then evaluated for particle size, polydispersity index, zeta potential, pH and drug release. The optimized ethosome formula then converted to gel. The gel evaluated for organoleptic properties, pH, viscosity and permeability. Results: The results showed than F8 was the best ethosomal formula with 34nm in size and 92% entrapment efficiency. This formula converted into gel had 1% gelling agent that was optimized ethosomal gel formula and gave better release that ordinary methotrexate gel with same type and percent of gelling agent. Conclusions: The drug was successfully formulated as ethosomal gel for treating cervical cancer topically in order to avoid the systemic exposure for the chemotherapy and its consequence adverse effect.